title: The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
abstract: Mutant viruses with deletions in genes encoding non-essential glycoproteins are considered as promising bovine herpesvirus 1 (BHV1) vaccine candidates. The present study compared the influence of various gene deletions (gC, gE, gI, gG) on the induction of cell-mediated immune responses against the virus. The highest BHV1 specific lymphoproliferative response was observed in the group of calves inoculated with the gC- mutant. However, in all groups of inoculated calves, limiting dilution analysis showed marked individual variability in the number of BHV1 specific T lymphocytes that were stimulated. The same animals were then challenged with wild-type BHV1. In these animals, limiting dilution analysis did not reveal gE, gI nor gG as a major T lymphocyte antigen. However, further analysis suggested the T cell antigenicity of gE in a low number of BHV1 hyperimmunized calves. Stimulation of MHC unrestricted cytotoxicity was also evaluated after inoculation with the various deletion mutants. Cytotoxicity in gC- inoculated calves was as high as in BHV1 inoculated calves. In conclusion, among the BHV1 deletion mutants that were tested, the gC- mutant stimulated the best cell-mediated immune responses.
authors.affiliation: Dept. of Virology and Immunology, Faculty of Veterinary Medicine, University of Liège, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Denis
authors.forename: E
authors.initials: E
authors.lastname: Hanon
authors.forename: F A
authors.initials: FA
authors.lastname: Rijsewijk
authors.forename: M J
authors.initials: MJ
authors.lastname: Kaashoek
authors.forename: J T
authors.initials: JT
authors.lastname: van Oirschot
authors.forename: E
authors.initials: E
authors.lastname: Thiry
authors.forename: P P
authors.initials: PP
authors.lastname: Pastoret
mesh_terms: D000818:Animals; D002417:Cattle; D002418:Cattle Diseases; D003602:Cytotoxicity, Immunologic; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D007242:Herpesvirus 1, Bovine / Q000235:genetics / Q000276:immunology*; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D016296:Mutagenesis; D017384:Sequence Deletion; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology*; D014765:Viral Vaccines
chemical_list: D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C046998:bovine herpesvirus type-1 glycoproteins